* files open in new windows
As you are aware, we are facing uncertain economic times which have contributed to a record increase in client enrollment. The lingering economic downturn has forced us to take cost containment measures to ensure currently-enrolled clients continue to receive their medications without disruption in medical treatment.
Beginning June 1, 2010 the Florida AIDS Drug Assistance Program (ADAP)
has instituted a waiting list. The purpose of the waiting list is to ensure availability of HIV treatment medications for all ADAP clients currently enrolled. Also, effective August 1, 2010 the ADAP formulary will be reduced to Antiretroviral (ARV) and Opportunistic Infection (OI) medications.
In our efforts to provide a time-sensitive, solution-based response, we have assembled this
Comprehensive Cost Containment Guidance (1.6MB and opens in new window) to ensure ADAP staff, case managers, and providers have the necessary tools to assist clients.
Please note: Pregnant women, pediatric or adolescent individuals who meet ADAP enrollment criteria and are not eligible for other programs are exempt from being placed on the waiting list and will be immediately enrolled for services. Providers can request a medical review for patient(s) who have an extreme medical condition. Reviews and approval will be done by the HIV/AIDS and Hepatitis Program's medical staff.
We recognize that maintaining a sustainable drug assistance program is a critical need in our state.HIV/AIDS and Hepatitis Programis currently working with Federal and State government officials as well as statewide community partners to secure additional resources. Every effort in reducing the impact of any cost containment measures is carefully considered and evaluated to ensure the most effective and proactive response during these challenging times.
HIV/AIDS and Hepatitis Program,
AIDS Drug Assistance Program
Other important Documents
All PDF files are under 10MB and open in new windows